1. Home
  2. HQI vs ELDN Comparison

HQI vs ELDN Comparison

Compare HQI & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

N/A

Current Price

$16.87

Market Cap

232.1M

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$3.02

Market Cap

186.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HQI
ELDN
Founded
2002
2004
Country
United States
United States
Employees
75000
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.1M
186.9M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
HQI
ELDN
Price
$16.87
$3.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $19.00
$9.00
AVG Volume (30 Days)
25.3K
★ 849.8K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
★ 1.47%
N/A
EPS Growth
★ 73.08
30.67
EPS
★ 0.31
N/A
Revenue
★ $30,640,000.00
N/A
Revenue This Year
$0.54
N/A
Revenue Next Year
$5.47
N/A
P/E Ratio
$52.90
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.38
$1.35
52 Week High
$20.84
$4.60

Technical Indicators

Market Signals
Indicator
HQI
ELDN
Relative Strength Index (RSI) 49.34 66.56
Support Level $15.28 $2.63
Resistance Level $18.49 $3.18
Average True Range (ATR) 0.95 0.21
MACD -0.09 0.11
Stochastic Oscillator 48.91 77.55

Price Performance

Historical Comparison
HQI
ELDN

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: